The global transcatheter aortic valve replacement (TAVR) market is growing rapidly in both developed and emerging markets. The market is poised for substantial expansion over the next decade, reflecting both demographic trends and clinical innovation. Edwards Lifesciences has established itself as the global leader in the TAVR market. The company reported an 8.9 per cent year-over-year (YoY) growth in TAVR sales for Q2 2025. It has also seen strong growth continuing into July 2025, according to GlobalData.
Early reports from GlobalData, consisting of data from a panel of 2,600 US medical facilities, suggests that Edwards Lifesciences continued to see sales momentum in July 2025, with the SAPIEN 3 product lines making up a large share of sales. The company currently holds over 60 per cent of global TAVR market share and 75 per cent in the US, according to GlobalData estimates.
Thomas Fleming, Medical Analyst at GlobalData, comments, “TAVR is indicated for patients with severe symptomatic aortic stenosis, a condition characterised by narrowing of the aortic valve tissue, often due to calcification that builds with age. The prevalence of aortic stenosis rises sharply with age and demographic shifts will play a key role in driving demand. The United Nations projects that the number of individuals aged 80 and above will triple by 2050, which will drive TAVR demand.”
According to GlobalData, the TAVR market is projected to see a compound annual growth rate (CAGR) of 8 per cent worldwide between 2024 and 2034, with the US market forecasted to grow at a 6 per cent CAGR during the same period.
Compared to surgical aortic valve replacement (SAVR), TAVR offers several advantages. TAVR is minimally invasive, which results in shorter recovery times and is less intensive on patients. TAVR results in patient survival and improvement that is as good or better than that of SAVR
Fleming concludes, “Over 500,000 procedures have been performed in over 70 countries. TAVR is quickly developing from a challenging procedure to a standardised one, as more physicians are being trained in this technique globally.”